This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.DJ Gubler . Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends in Microbiology 2002; 10: 100–103.
. Geographic expansion of dengue: the impact of international travel. Medical Clinics of North America
2008; 92: 1377–1390.
3.A Wilder-Smith , Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Current Infectious Diseases Report 2010; 12: 157–164.
4.C Heintzem , M Velasco Garrido , A Kroeger . What do community-based dengue control programmes achieve? A systematic review of published evaluations. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007; 101: 317–325.
5.K Heggenhougen , V Hackethal , P Vivek . The behavioural and social aspects of malaria and its control. WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, 2003, TDR/STR/SEB/VOL/031.
Controlling dengue with vaccines in Thailand. PLoS Neglected Tropical Diseases
2012; 6: e1876.
8.M Amaku , L Coudeville , E Massad . Designing a vaccination strategy against dengue. Revista do Instituto de Medicina Tropical de Sao Paulo 54 (Suppl. 18): S18–S21.
9.Gonzalez K Perez , SA Domingo , R Hartnoll . Prevalence of human immunodeficiency virus and risk behaviours among opioid users in an emergency room. Gaelic Sanitatis 1999; 13: 7–15.
Modeling the impact of imperfect HIV vaccines on the incidence of the infection. Mathematical and Computer Modelling
2001; 34: 345–351.
Modelling the control strategies against dengue in Singapore. Epidemiology and Infection
2008; 136: 309–319.
13.FAB Coutinho , Threshold conditions for a non-autonomous epidemic system describing the population dynamics of dengue. Bulletin of Mathematical Biology 2006; 68: 2263–2282.
14.LF Lopez , Threshold conditions for infection persistence in complex host-vector interactions. Compte Rendus Biologies 2002; 325: 1073–1084.
16.M Bland . An Introduction to Medical Statistics, 3rd edn. Oxford: Oxford University Press, 2000.
17.E Massad , MN Burattini , NRS Ortega . Fuzzy logic and measles vaccination: designing a control strategy. International Journal of Epidemiology 1999; 28: 550–557.
18.Neto RS Azevedo , (1994). Rubella seroepidemiology in a non-immunized population of São Paulo State, Brazil. Epidemiology and Infections 113: 161–173.
and the Yellow Fever Working Group. Reemergence of yellow fever: detection of transmission in the state of São Paulo, Brazil. Revista da Sociedade Brasileira de Medicina Tropical
2011; 44: 290–296.
20.YS Leo , Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2–45 y. Phase II randomized controlled trial in Singapore. Human Vaccines & Immunotherapeutics 2012; 8: 1259–1271.
21.N Kanesa-thasan , Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 2001; 19: 3179–3188.
22.A Sabchareon , Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012; 380: 1559–1567.